- Home
- FFIC vs MXCT Comparison
FFIC vs MXCT Comparison
Compare FFIC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIC
- MXCT
- Stock Information
- Founded
- FFIC 1929
- MXCT 1999
- Country
- FFIC United States
- MXCT United States
- Employees
- FFIC N/A
- MXCT N/A
- Industry
- FFIC Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FFIC Finance
- MXCT Health Care
- Exchange
- FFIC Nasdaq
- MXCT Nasdaq
- Market Cap
- FFIC 446.9M
- MXCT 361.8M
- IPO Year
- FFIC 1995
- MXCT 2021
- Fundamental
- Price
- FFIC $12.78
- MXCT $2.76
- Analyst Decision
- FFIC Hold
- MXCT Strong Buy
- Analyst Count
- FFIC 3
- MXCT 2
- Target Price
- FFIC $16.17
- MXCT $10.00
- AVG Volume (30 Days)
- FFIC 356.2K
- MXCT 682.5K
- Earning Date
- FFIC 04-29-2025
- MXCT 05-06-2025
- Dividend Yield
- FFIC 6.88%
- MXCT N/A
- EPS Growth
- FFIC N/A
- MXCT N/A
- EPS
- FFIC N/A
- MXCT N/A
- Revenue
- FFIC $115,172,000.00
- MXCT $38,627,000.00
- Revenue This Year
- FFIC $107.88
- MXCT $9.05
- Revenue Next Year
- FFIC $9.20
- MXCT $19.98
- P/E Ratio
- FFIC N/A
- MXCT N/A
- Revenue Growth
- FFIC N/A
- MXCT N/A
- 52 Week Low
- FFIC $10.74
- MXCT $2.62
- 52 Week High
- FFIC $18.59
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- FFIC 37.46
- MXCT 30.42
- Support Level
- FFIC $12.50
- MXCT $2.62
- Resistance Level
- FFIC $13.48
- MXCT $3.17
- Average True Range (ATR)
- FFIC 0.33
- MXCT 0.17
- MACD
- FFIC 0.00
- MXCT -0.01
- Stochastic Oscillator
- FFIC 27.18
- MXCT 19.72
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.